Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis : report of two cases and literature review
Eosinophilic fasciitis (EF) is an uncommon autoimmune connective tissue disorder characterized by edema, erythema, and subsequent induration of the extremities. It is commonly treated with corticosteroids but there is no treatment ladder for immunosuppressants or steroid-sparing agents. We report two EF cases treated effectively with mycophenolate mofetil (MMF) or mycophenolic acid (MPA) and present a literature review. We performed a MEDLINE search using the keywords 'eosinophilic fasciitis', 'Shulman syndrome', 'mycophenolic acid', or 'mofetil mycophenolate', and found 8 articles with 27 cases in which MMF or MPA was used. Twenty-nine cases were reviewed (2 reported herein and 27 from the literature search); all patients received a combination of systemic corticosteroids and MMF. MMF/MPA were given as a steroid-sparing agent in 27 (93.1%), in 1 (3.4%) as adjunctive therapy with other immunosuppressants, and in one, as monotherapy 1 (3.4%). Nineteen had a complete response, 6, a partial response, and 2 were unresponsive to diverse immunomodulators; in 2 cases, the outcome was not reported. MMF and MPA show promising therapeutic results and could be a treatment option to reduce corticosteroid related side effects.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
The Journal of dermatological treatment - 33(2022), 3 vom: 19. Mai, Seite 1765-1768 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Moreno-Arquieta, Ilse Andrea [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.08.2022 Date Revised 25.08.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09546634.2021.1890682 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321745175 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321745175 | ||
003 | DE-627 | ||
005 | 20231225180534.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09546634.2021.1890682 |2 doi | |
028 | 5 | 2 | |a pubmed24n1072.xml |
035 | |a (DE-627)NLM321745175 | ||
035 | |a (NLM)33615948 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Moreno-Arquieta, Ilse Andrea |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis |b report of two cases and literature review |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.08.2022 | ||
500 | |a Date Revised 25.08.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Eosinophilic fasciitis (EF) is an uncommon autoimmune connective tissue disorder characterized by edema, erythema, and subsequent induration of the extremities. It is commonly treated with corticosteroids but there is no treatment ladder for immunosuppressants or steroid-sparing agents. We report two EF cases treated effectively with mycophenolate mofetil (MMF) or mycophenolic acid (MPA) and present a literature review. We performed a MEDLINE search using the keywords 'eosinophilic fasciitis', 'Shulman syndrome', 'mycophenolic acid', or 'mofetil mycophenolate', and found 8 articles with 27 cases in which MMF or MPA was used. Twenty-nine cases were reviewed (2 reported herein and 27 from the literature search); all patients received a combination of systemic corticosteroids and MMF. MMF/MPA were given as a steroid-sparing agent in 27 (93.1%), in 1 (3.4%) as adjunctive therapy with other immunosuppressants, and in one, as monotherapy 1 (3.4%). Nineteen had a complete response, 6, a partial response, and 2 were unresponsive to diverse immunomodulators; in 2 cases, the outcome was not reported. MMF and MPA show promising therapeutic results and could be a treatment option to reduce corticosteroid related side effects | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Eosinophilic fasciitis | |
650 | 4 | |a Shulman syndrome | |
650 | 4 | |a case series | |
650 | 4 | |a mycophenolate mofetil | |
650 | 4 | |a mycophenolic acid | |
650 | 4 | |a treatment | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
650 | 7 | |a Mycophenolic Acid |2 NLM | |
650 | 7 | |a HU9DX48N0T |2 NLM | |
700 | 1 | |a Cardenas-de la Garza, Jesus Alberto |e verfasserin |4 aut | |
700 | 1 | |a Esquivel-Valerio, Jorge Antonio |e verfasserin |4 aut | |
700 | 1 | |a Riega-Torres, Janett |e verfasserin |4 aut | |
700 | 1 | |a Cuellar-Barboza, Adrian |e verfasserin |4 aut | |
700 | 1 | |a Herz-Ruelas, Maira Elizabeth |e verfasserin |4 aut | |
700 | 1 | |a Ocampo-Candiani, Jorge |e verfasserin |4 aut | |
700 | 1 | |a Galarza-Delgado, Dionicio Angel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of dermatological treatment |d 1992 |g 33(2022), 3 vom: 19. Mai, Seite 1765-1768 |w (DE-627)NLM088851680 |x 1471-1753 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2022 |g number:3 |g day:19 |g month:05 |g pages:1765-1768 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09546634.2021.1890682 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2022 |e 3 |b 19 |c 05 |h 1765-1768 |